Discontinued — last reported Q4 '10

Finite Lived Intangible Assets - Gross

Non-Current Assets

Amgen Finite Lived Intangible Assets - Gross increased by 3.5% to $31.87B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.9%, from $27.27B to $31.87B. Over 4 years (FY 2020 to FY 2024), Finite Lived Intangible Assets - Gross shows an upward trend with a 37.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2009
Last reportedQ4 2010

How to read this metric

An increase suggests active acquisition of intellectual property or business assets, while a decrease may indicate asset retirement or impairment.

Detailed definition

This represents the total historical cost of intangible assets with a defined useful life, such as patents, trademarks,...

Peer comparison

Standard across capital-intensive and technology-driven firms; peers often report this to show investment in intangible growth.

Metric ID: finite_lived_intangible_assets_gross

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$16.74B$17.37B$17.99B$18.60B$19.19B$19.77B$20.53B$21.23B$21.92B$22.62B$55.23B$24.86B$26.05B$27.27B$55.06B$29.62B$30.79B$31.87B
QoQ Change+3.8%+3.5%+3.4%+3.2%+3.0%+3.8%+3.4%+3.2%+3.2%+144.2%-55.0%+4.8%+4.7%+101.9%-46.2%+3.9%+3.5%
YoY Change+14.6%+13.8%+14.1%+14.1%+14.2%+14.4%+169.1%+17.1%+18.9%+20.6%-0.3%+19.2%+18.2%+16.9%
Range$16.74B$55.23B
CAGR+16.4%
Avg YoY Growth+26.1%
Median YoY Growth+15.7%
Current Streak2 quarters growth

Frequently Asked Questions

What is Amgen's finite lived intangible assets - gross?
Amgen (AMGN) reported finite lived intangible assets - gross of $31.87B in Q3 2025.
How has Amgen's finite lived intangible assets - gross changed year-over-year?
Amgen's finite lived intangible assets - gross increased by 16.9% year-over-year, from $27.27B to $31.87B.
What is the long-term trend for Amgen's finite lived intangible assets - gross?
Over 4 years (2020 to 2024), Amgen's finite lived intangible assets - gross has grown at a 37.4% compound annual growth rate (CAGR), from $15.46B to $55.06B.
What does finite lived intangible assets - gross mean?
The total original cost of intangible assets that have a limited lifespan.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.